Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedUpdate to a newer revision identifier (v3.2.0) replaces the older v3.0.2.SummaryDifference0.1%
- Check16 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes detected.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedUpdated the page version from v3.0.1 to v3.0.2 and removed the 'Back to Top' link; no changes to core content, pricing, or availability.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%
- Check44 days agoChange DetectedThe webpage has undergone significant updates, including the addition of various facility names and locations across multiple countries, while also removing outdated location references and terms. Notably, the term 'IgA Nephropathy' has been replaced with 'IgA glomerulonephritis', indicating a shift in terminology.SummaryDifference10%
- Check51 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.2%
Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.